NxStage Medical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 8 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-05-21: Reporting owner Turk Joseph E Jr; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-05-17: Reporting owner REID PERPER; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-05-17: Reporting owner Giannini Daniel A; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-05-16: Reporting owner MOORE CRAIG W; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-05-21 | Turk Joseph E Jr Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,392 0 owned after | $18.59 exercise price | 2018-05-21 | |
| 2018-05-17 | REID PERPER Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,196 0 owned after | $13.60 exercise price | 2018-05-18 | |
| 2018-05-17 | Giannini Daniel A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,196 0 owned after | $13.60 exercise price | 2018-05-18 | |
| 2018-05-16 | MOORE CRAIG W Director | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,496 0 owned after | $13.60 exercise price | 2018-05-18 | |
| 2018-05-16 | MOORE CRAIG W Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,700 0 owned after | $13.60 exercise price | 2018-05-18 | |
| 2018-03-14 | Burbank Jeffrey H Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,273 0 owned after | $18.59 exercise price | 2018-03-16 | |
| 2018-02-20 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 11,542 owned after | $11.03 exercise price | 2018-02-22 | |
| 2018-01-16 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 14,542 owned after | $11.03 exercise price | 2018-01-19 |